GENE logo.png
New Precision Oncology Tests to Drive Personalised Therapies and Improved Treatment Outcomes
17 avr. 2024 08h00 HE | Genetic Technologies Ltd
New Precision Oncology Tests to Drive Personalised Therapies and Improved Treatment Outcomes
Bionano_RGB.png
Bionano and Diagens Sign Partnership to Commercialize the First Ever Clinical Cytogenetic Analysis that Combines OGM and Artificial Intelligence
17 avr. 2024 08h00 HE | Bionano Genomics
Bionano and Diagens form strategic partnership to commercialize OGM plus AI cytogenetic analysis for reproductive health in China.
22157.jpg
Viral Vector and Plasmid DNA Technologies Market Outlook 2024-2028: Innovations, Technological Advances and Product Launches from Leading Companies
05 avr. 2024 04h02 HE | Research and Markets
Dublin, April 05, 2024 (GLOBE NEWSWIRE) -- The "Viral Vector and Plasmid DNA: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering. The global market for...
22157.jpg
Global Cell and Gene Therapy Markets Report 2024-2028 Featuring Main Players - Mallinckrodt, Vericel, Gilead Sciences, Pharmicell, and Bristol-Myers Squibb
03 avr. 2024 03h10 HE | Research and Markets
Dublin, April 03, 2024 (GLOBE NEWSWIRE) -- The "Global Cell and Gene Therapy Market" report has been added to ResearchAndMarkets.com's offering. The Global Cell and Gene Therapy Market is...
Bionano_RGB.png
Bionano Announces 9 Poster Presentations and Introduces New High Throughput Stratys™ System at the American Association for Cancer Research Annual Meeting
02 avr. 2024 08h00 HE | Bionano Genomics
Bionano will unveil new genome analysis solutions for cancer research at the upcoming AACR annual conference in San Diego, California.
Logo.jpg
ProPhase Labs Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
01 avr. 2024 21h00 HE | ProPhase Labs, Inc.
Garden City, NY, April 01, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next-generation biopharma, genomics, and diagnostics company, today announced...
22157.jpg
North America Nutrigenomics Market By Product (Reagents & Kits, and Services), End User (Hospitals & Clinics, Online Platforms, and Others), Application, Country and Growth Forecast to 2030
27 mars 2024 13h56 HE | Research and Markets
Dublin, March 27, 2024 (GLOBE NEWSWIRE) -- The "North America Nutrigenomics Market Size, Share & Trends Analysis Report By Product (Reagents & Kits, and Services), By End User (Hospitals...
approved logo.JPG
CHARM Therapeutics Announces Foundation of Scientific Advisory Board (SAB)
19 mars 2024 10h00 HE | Charm Therapeutics
PRESS RELEASE CHARM Therapeutics Announces Foundation of Scientific Advisory Board (SAB) LONDON – 19 March 2024 -- CHARM Therapeutics (“CHARM”, “The Company”), a 3D deep-learning research company...
Bionano_RGB.png
Bionano Announces Publication of a Breast Cancer Study Showing that the Number of SVs Detected with OGM May Be Related to Prognosis, Tumor Progression and Chemotherapy Resistance
19 mars 2024 08h00 HE | Bionano Genomics
SAN DIEGO, March 19, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the publication of a study of optical genome mapping (OGM) in hereditary breast and ovarian cancer...
22157.jpg
Precision Medicine Market Deal Making Trends: "Precision Medicine Collaboration and Licensing Deals (2016-2023)" Comprehensive Report Released
18 mars 2024 05h39 HE | Research and Markets
Dublin, March 18, 2024 (GLOBE NEWSWIRE) -- The "Precision Medicine Collaboration and Licensing Deals 2016-2023" report has been added to ResearchAndMarkets.com's offering. The realm of precision...